Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (6): 1135-1139. doi: 10.19723/j.issn.1671-167X.2020.06.025

Previous Articles     Next Articles

Rheumatoid arthritis combined with pigmented villonodular synovitis: A case report and literature review

Jia-jing PENG,Tian LIU()   

  1. Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing 100044, China
  • Received:2020-07-25 Online:2020-12-18 Published:2020-12-13
  • Contact: Tian LIU E-mail:mikle317@163.com

RICH HTML

  

Abstract:

We reported a case of rheumatoid arthritis (RA) combined with pigmented villonodular synovitis (PVNS) from Peking University People’s Hospital. The clinical data were introduced and the related literature was reviewed. The clinical features, treatment and prognosis of the disease were summarized to improve clinicians’ understanding of this rare disease and avoid misdiagnosis and delayed diagnosis. A 45-year-old female, with 15 years of RA history and unregular treatment, was admitted to the hospital with the complaint of aggravating pain and swelling in the right knee for 3 months. The puncture of the right knee was performed and there was a large amount of bloody synovial fluid that could not be explained by her RA history. Moreover, the magnetic resonance imaging (MRI) of the right knee revealed hemosiderin deposition with low-intensity signals on both T1-weighted and T2-weighted images which suggested PVNS to us. Then, the patient underwent knee arthroscopy and biopsy to assist in diagnosis. The arthroscopic appearance and pathology were consistent with PVNS and the hyperplastic synovium was removed during arthroscopy. After the operation, she did active functional exercises and took disease-modifying antirheumatic drugs to control RA. She recovered well and remained asymptomatic after half a year of follow-up. Also, there was no recurrence of the right knee. As we all know, RA is a systemic autoimmune disease characterized by chronic synovitis and joint damage. And PVNS is characterized by synovial proliferation and infiltrative process. Both of them are synovial involvement and the clinical manifestations are quite similar. PVNS has occasionally been reported in association with RA. So it is difficult to make a clear diagnosis of RA combined with PVNS. Literature was searched with RA+PVNS in the WanFang Medical Network Database and China National Knowledge Infrastructure and there were no related Chinese cases. Then we searched literature from PubMed with RA+PVNS. The cases were still rare and eventually 2 related articles were yielded including 2 similar patients. It is necessary to fully understand the disease development, complicated MRI appearance and various pathological morpho-logy. They can contribute to making a correct diagnosis which is effective to guide the proper treatment.

Key words: Pigmented villonodular synovitis, Rheumatoid arthritis, Synovial fluid, Hemarthrosis

CLC Number: 

  • R593.22

Figure 1

Arthroscopic appearance Arthroscope showed synovial hypertrophy was diffuse, the multiple definite nodules were seen."

Figure 2

Postoperative pathology (HE ×100) Histological image showed villous formation with giant cells stained hemosiderin, proliferation of small blood vessels and interstitial fibrous tissue with hyaline change."

Table 1

Clinical data of 3 rheumatoid arthritis patients combined with pigmented villonodular synovitis"

Study Gender Age/years Duration/years Affected
joints of PVNS
Affected joints of RA WBC/
(×109/L)
HB/
(g/L)
PLT/
(×109/L)
This study Female 45 15 Right knee Wrist, MCP, PIP, knee 4 129 188
Hirose et al[3] Female 38 5.3 Right knee Wrist, MCP, ankle, knee 3.5 121 300
Zhao et al[4] Male 56 3 Right knee Wrist, MCP, PIP, knee - - -
Study ESR/(mm/h) CRP/(mg/L) RF/(IU/mL) Anti-CCP/(U/mL) MRI Synovial fluid Arthroscopy Radiation
therapy
This study 11 0.39 <20 137.9 Soft-tissue mass
with low intensity signals
on T1-weighted and
T2-weighted images(all
these three patients had
such MRI manifestations)
Bloody Once No
Hirose et al[3] 82 2.7 151 - Bloody Twice Yes
Zhao et al[4] 34 44.6 238 >200 Bloody Once No
[1] Croia C, Bursi R, Sutera D, et al. One year in review 2019: pathogenesis of rheumatoid arthritis[J]. Clin Exp Rheumatol, 2019,37(3):347-357.
pmid: 31111823
[2] Ottaviani S, Ayral X, Dougados M, et al. Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature[J]. Semin Arthritis Rheum, 2011,40(6):539-546.
doi: 10.1016/j.semarthrit.2010.07.005 pmid: 20884045
[3] Hirose I, Mori Y, Fujimoto A. Case report: rheumatoid arthritis occurring during observation after surgery for localized pigmented villonodular synovitis[J]. Mod Rheumatol, 2003,13(3):281-284.
pmid: 24387219
[4] Zhao X, Ji W, Qian X, et al. Pigmented villonodular synovitis developing in a patient with rheumatoid arthritis[J]. J Clin Rheumatol, 2014,20(5):283-286.
doi: 10.1097/RHU.0000000000000119 pmid: 25036563
[5] Dougados M. Synovial fluid cell analysis[J]. Baillieres Clin Rheumatol, 1996,10(3):519-534.
pmid: 8876957
[6] Myers BW, Masi AT. Pigmented villonodular synovitis and tenosynovitis: A clinical epidemiologic study of 166 cases and literature review[J]. Medicine (Baltimore), 1980,59(3):223-238.
[7] Mastboom M, Verspoor F, Verschoor A, et al. Higher incidence rates than previously known in tenosynovial giant cell tumors[J]. Acta orthopaedica, 2017,88(6):688-694.
doi: 10.1080/17453674.2017.1361126 pmid: 28787222
[8] Fiocco U, Sfriso P, Lunardi F, et al. Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis[J]. Autoimmun Rev, 2010,9(11):780-784.
doi: 10.1016/j.autrev.2010.07.001 pmid: 20620241
[9] Gouin F, Noailles T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)[J]. Orthop Traumatol Surg Res, 2017,103(1S):S91-S97.
doi: 10.1016/j.otsr.2016.11.002 pmid: 28057477
[10] Staals E, Ferrari S, Donati D, et al. Diffuse-type tenosynovial giant cell tumour: Current treatment concepts and future perspectives[J]. Eur J Cancer, 2016,63:34-40.
doi: 10.1016/j.ejca.2016.04.022 pmid: 27267143
[11] Cupp J, Miller M, Montgomery K, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides[J]. Am J Surg Pathol, 2007,31(6):970-976.
doi: 10.1097/PAS.0b013e31802b86f8 pmid: 17527089
[12] Oliviero F, Galozzi P, Ramonda R, et al. Unusual findings in synovial fluid analysis: A review[J]. Ann Clin Lab Sci, 2017,47(3):253-259.
pmid: 28667024
[13] 列锐锋. 膝关节色素沉着绒毛结节性滑膜炎MRI表现[J]. 罕少疾病杂志, 2020,27(2):67-69.
[14] Houdek MT, Scorianz M, Wyles CC, et al. Long-term outcome of knee arthroplasty in the setting of pigmented villonodular synovitis[J]. Knee, 2017,24(4):851-855.
doi: 10.1016/j.knee.2017.04.019 pmid: 28552192
[15] Barile A, Sabatini M, Iannessi F, et al. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled[J]. Radiol Med, 2004,107(4):356-366.
pmid: 15103287
[16] 巫娟, 徐钢, 傅静. 膝关节色素沉着绒毛结节性滑膜炎的临床病理分析[J]. 四川医学, 2017,38(9):1010-1013.
[17] Bernthal N, Ishmael C, Burke Z. Management of pigmented villonodular synovitis (PVNS): an orthopedic surgeon’s perspective[J]. Curr Oncol Rep, 2020,22(6):63.
pmid: 32494892
[18] Palmerini E, Staals E, Maki R, et al. Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors[J]. Eur J Cancer, 2015,51(2):210-217.
doi: 10.1016/j.ejca.2014.11.001 pmid: 25465190
[19] Tap W, Gelderblom H, Palmerini E, et al. Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial[J]. Lancet, 2019,394(10197):478-487.
doi: 10.1016/S0140-6736(19)30764-0 pmid: 31229240
[20] Monestime S, Lazaridis D. Pexidartinib (TURALIO?): The first FDA-indicated systemic treatment for tenosynovial giant cell tumor[J]. Drugs R D, 2020,20(3):189-195.
doi: 10.1007/s40268-020-00314-3 pmid: 32617868
[21] Gelderblom H, Cropet C, Chevreau C, et al. Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial[J]. Lancet Oncol, 2018,19(5):639-648.
doi: 10.1016/S1470-2045(18)30143-8 pmid: 29571946
[1] Hui WEI, Jingfeng ZHANG, Zhongqiang YAO, Jinxia ZHAO. Clinical characteristics and relevant factors of rheumatoid arthritis patients with anemia of chronic disease [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 307-312.
[2] Tao WU, Jianzi LIN, Yafeng ZHU, Jianda MA, Peiwen JIA, Lijuan YANG, jie PAN, Yaowei ZOU, Ying YANG, Ye LU, Lie DAI. Serum inter-alpha-trypsin inhibitor heavy chain H3 is identified as a potential biomarker for myopenia in patients with rheumatoid arthritis using proteomic profiling [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1024-1031.
[3] Yan DING, Lifang WANG, Chaoran LI, Zhemin LU, Lianjie SHI. Rheumatoid arthritis combined with IgG4-related disease successfully treated with rituximab: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1203-1207.
[4] Ju YANG, Jing XU, Juhua DAI, Lianjie SHI. Expression of lumican protein in serum of patients with rheumatoid arthritis and its correlation with disease and immune activities [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 911-918.
[5] Lianghua FENG, Lirong HONG, Yujia CHEN, Xueming CAI. Role and mechanism of ubiquitin-specific protease 35 in ferroptosis of rheumatoid arthritis-fibroblast like synoviocytes [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 919-925.
[6] Peiwen JIA, Ying YANG, Yaowei ZOU, Zhiming OUYANG, Jianzi LIN, Jianda MA, Kuimin YANG, Lie DAI. Clinical characteristics of overlapping syndromes of low muscle mass in patients with rheumatoid arthritis and their impact on physical function [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1009-1016.
[7] Doudou MA, Zhemin LU, Qian GUO, Sha ZHU, Jin GU, Yan DING, Lianjie SHI. Successful treatment of rheumatoid arthritis complicated with myasthenia gravis with low-dose rituximab: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1110-1114.
[8] Rui YAN, Dan KE, Yan ZHANG, Li LI, Huanran SU, Wei CHEN, Mingxia SUN, Xiaomin LIU, Liang LUO. Diagnostic significance of serum chemokine CXCL-10 and Krebs von den lungen-6 level in patients with rheumatoid arthritis associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 956-962.
[9] Liang ZHAO, Chenglong SHI, Ke MA, Jing ZHAO, Xiao WANG, Xiaoyan XING, Wanxing MO, Yirui LIAN, Chao GAO, Yuhui LI. Immunological characteristics of patients with anti-synthetase syndrome overlap with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 972-979.
[10] Yijun HAN, Xiaoli CHEN, Changhong LI, Jinxia ZHAO. Application status of methotrexate in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 994-1000.
[11] Dongwu LIU, Jie CHEN, Mingli GAO, Jing YU. Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 928-931.
[12] Huina HUANG,Jing ZHAO,Xiangge ZHAO,Ziran BAI,Xia LI,Guan WANG. Regulatory effect of lactate on peripheral blood CD4+ T cell subsets in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 519-525.
[13] Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283.
[14] Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021.
[15] Qi WU,Yue-ming CAI,Juan HE,Wen-di HUANG,Qing-wen WANG. Correlation between dyslipidemia and rheumatoid arthritis associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 982-992.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!